Beta Bionics (BBNX) FCF Margin (2024 - 2026)
Beta Bionics recorded quarterly FCF Margin of 91.25% in Q1 2026, down 111.08% quarter-over-quarter from 43.23% in Q4 2025, and up 2388.0% year-over-year from 3.67% in Q1 2025.
Beta Bionics' FCF Margin history runs 3 years deep, the most recent figure standing at 91.25% for Q1 2026.
- In Q1 2026, FCF Margin rose 2388.0% year-over-year to 91.25%; the TTM figure through Mar 2026 stood at 55.45% (up 2965.0% YoY), while the FY2025 annual figure was 56.08%, up 2326.0% from the prior year.
- FCF Margin came in at 91.25% for Q1 2026 at Beta Bionics, down from 43.23% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 31.8% in Q3 2025 to a low of 115.13% in Q1 2025.
- A 3-year average of 73.59% and a median of 72.6% in 2024 frame the typical range for FCF Margin.
- On a YoY basis, FCF Margin climbed as much as 3699 bps in 2025 and fell as far as 1809 bps in 2025.
- Beta Bionics' FCF Margin stood at 72.6% in 2024, then jumped by 40 bps to 43.23% in 2025, then sank by 111 bps to 91.25% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 91.25%, 43.23%, and 31.8% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Beta Bionics | 572.34 Mn | 542.03 Mn | 16.44 Mn | -91.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.25% |
| Dec 31, 2025 | -43.23% |
| Sep 30, 2025 | -31.80% |
| Jun 30, 2025 | -57.50% |
| Mar 31, 2025 | -115.13% |
| Dec 31, 2024 | -72.60% |
| Sep 30, 2024 | -68.79% |
| Jun 30, 2024 | -84.99% |
| Mar 31, 2024 | -97.04% |